Alexithymia in patients with substance use disorders: State or trait?
| Autor: | Cor A.J. de Jong, Jacobus Adrianus Maria van der Palen, Hein A. de Haan, Toon A. G. M. Wijdeveld, Jan K. Buitelaar |
|---|---|
| Přispěvatelé: | Faculty of Behavioural, Management and Social Sciences |
| Rok vydání: | 2014 |
| Předmět: |
Adult
Male medicine.medical_specialty Substance-Related Disorders media_common.quotation_subject IR-91851 METIS-305124 Experimental Psychopathology and Treatment Toronto Alexithymia Scale Alexithymia Regression toward the mean medicine Humans Personality Affective Symptoms Psychiatry Biological Psychiatry media_common Psychological Tests Neurodevelopmental disorders Donders Center for Medical Neuroscience [Radboudumc 7] medicine.diagnostic_test Other Research Radboud Institute for Health Sciences [Radboudumc 0] Middle Aged medicine.disease Substance Withdrawal Syndrome Substance abuse Psychiatry and Mental health Trait Anxiety Female Substance Abuse Treatment Centers medicine.symptom Substance use Psychology Follow-Up Studies |
| Zdroj: | Psychiatry Research, 216, 137-145 Psychiatry Research, 216, 1, pp. 137-45 Psychiatry Research, 216, 137-45 Psychiatry research, 216(1), 137-145. Elsevier Psychiatry Research, 216, 1, pp. 137-145 |
| ISSN: | 0165-1781 |
| Popis: | Item does not contain fulltext Previous research on substance use disorders (SUD) has yielded conflicting results concerning whether alexithymia is a state or trait, raising the question of how alexithymia should be addressed in the treatment of SUD-patients. The absolute and relative stabilities of alexithymia were assessed using the Toronto Alexithymia Scale (TAS-20) and its subscales. In total, 101 patients with SUD were assessed twice during a 3-week inpatient detoxification period while controlling for withdrawal symptoms and personality disorder traits. The relative stability of the total TAS-20 and subscales was moderate to high but showed remarkable differences between baseline low, moderate, and high alexithymic patients. A small reduction in the mean levels of the total TAS-20 scores and those of one subscale revealed the absence of absolute stability. The levels of alexithymia were unrelated to changes in withdrawal symptoms, including anxiety- and depression-like symptoms. The differences between low, moderate, and high alexithymic patients in terms of the change in alexithymia scores between baseline and follow-up indicated a strong regression to the mean. The findings suggest that alexithymia in SUD patients as measured using the TAS-20 is both a state and trait phenomenon and does not appear to be related to changes in anxiety- and depression-like symptoms. 9 p. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect